Advancing Complex Biologics into Real Treatments: Technologies, Experts and Part

Drug discovery and development are complex and require significant resources, expertise, and time. With the industry becoming more and more competitive, pharmaceutical companies need to utilize new approaches to launch products more efficiently. However, companies are still met with obstacles from regulatory guidelines to recruitment of clinical trials to other market competition

Join us as for this insightful conversation with pharma executive(s) to explore key barriers in advancing new treatments and how to navigate the uncertainty through the late phase clinical trials to launch. This session will explore how the pros and cons of leveraging cutting-edge technology to overcome challenges in the late phase and launch treatments and bring life-saving treatments to patients faster.